Concerns are growing among s*x workers and HIV prevention advocates following reported shortages of a long-acting anti-HIV injection that has become an important tool in the fight against new infections.
The injection, which offers extended protection against HIV, has been widely welcomed by people at higher risk of exposure, including s*x workers, because it reduces the need for taking daily prevention pills.
However, reports indicate that supplies have run low in some locations, leaving many users uncertain about when they will receive their next dose.
Why the injection matters
The long-acting injection is a form of pre-exposure prophylaxis (PrEP), a preventive treatment used by HIV-negative individuals to reduce their chances of contracting the virus. Research has shown that PrEP can significantly lower HIV infection risk when used correctly.
For many s*x workers, the injectable option is considered more convenient than daily medication because it requires fewer doses and can improve adherence to HIV prevention programmes.
Health experts say interruptions in access could increase anxiety among users who rely on the treatment for protection.
Fear of losing protection
Some users reportedly expressed concern that missing scheduled injections could leave them vulnerable to infection, especially those whose work involves frequent contact with multiple partners.
Advocates are urging health authorities and international partners to ensure a stable supply chain to prevent disruptions in HIV prevention services.
They argue that maintaining access to preventive healthcare is essential to sustaining progress made in reducing new HIV infections among vulnerable groups.
Calls for urgent action
Public health campaigners have called for quicker distribution of available supplies and better planning to avoid future shortages.
They warn that setbacks in prevention programmes could undermine years of efforts aimed at reducing HIV transmission rates.
Studies have shown that targeted HIV prevention services remain critical for populations facing elevated exposure risks, including s*x workers and other vulnerable groups.
What happens next?
Health stakeholders are expected to monitor the situation closely while efforts continue to restore supplies.
As for many affected users, the immediate concern is when fresh stock will arrive and whether access to the medication can be guaranteed in the coming months.
Also read: Nigeria’s hospitals: what patients face before they see a doctor
As health authorities work to address the shortage, advocates insist that uninterrupted access to HIV prevention tools must remain a priority in the broader fight against the virus.
